Hexagon Nutrition Board Approves Q1 FY27 Results, Recommends Dividend
Hexagon Nutrition Limited approved Q1 FY27 results and recommended a final dividend of ₹0.30 per share. The AGM is scheduled for September 22, 2026. Key management appointments and remuneration revisions were also approved, subject to member approval.
The announcement includes key corporate actions such as dividend recommendation, AGM scheduling, and director appointments, which have a moderate impact on stakeholders. The approval of financial results is routine.
The announcement reports on financial results and corporate actions, including dividend recommendation and board appointments. While these are routine, the financial results themselves were not provided in detail, and the outcome is largely procedural.
Hexagon Nutrition Limited announced the outcome of its Board Meeting held on August 12, 2026. The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report from the statutory auditors.
The company will convene its 33rd Annual General Meeting (AGM) on Tuesday, September 22, 2026, at 11:30 a.m. through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The book closure for the AGM will be from September 16, 2026, to September 22, 2026.
A final dividend of ₹0.30 Paise per equity share of face value ₹1 each for the financial year ended March 31, 2026, has been recommended. The record date for determining eligibility for this dividend is fixed as Tuesday, September 15, 2026.
The Board also approved revisions in the annual remuneration for Chairman and Executive Director Mr. Arun Purushottam Kelkar, Managing Director Mr. Vikram Arun Kelkar, and Joint Managing Director Dr. Nikhil Arun Kelkar, subject to member approval at the AGM. Furthermore, the re-appointment of Mr. Arun Purushottam Kelkar as Chairman & Director was recommended, pending member approval.
Mr. Raghunath Sawant has been appointed as an Additional Executive Director effective August 12, 2026. The alteration of the Articles of Association of the Company was also approved, subject to member approval. Additionally, the IPO Committee has been dissolved with immediate effect following the successful completion of the IPO.
The trading window for all Directors, Promoters, Connected Persons, Designated Persons, and their immediate relatives will open 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. The financial results will be available on the company's website.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.